Access key guidelines and consensus statements to support the identification and management of MAFLD. These resources promote consistent, evidence-based care across clinical settings.
| Title | Description | Link |
|---|---|---|
| ADS Livnig Guidelines | ADS Clinical Care Consensus Living Guideline for Specialist Assessment, Referral and Treatment of MAFLD in People with Diabetes (September 2025) | Click here |
| GESA MAFLD Guidelines | Recommendations for the assessment of MAFLD in primary care: a consensus statement | Click here |
| GESA MAFLD Assessment Algorithm | Assessment Algorithm for a Patient Presenting with MAFLD | Click here |
| GESA MAFLD screening recommendations & screening algorithm | Recommendations for the assessment of MAFLD in primary care | Click here |
The National Association of Diabetes Centres (NADC) is a national collective of organisations that are involved either directly or indirectly in diabetes services and care.
